Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
ROCHE PRODUCTS (NEW ZEALAND) LIMITED,Atezolizumab (with chemotherapy),"Extensive-stage small cell lung cancer (ES-SCLC), first-line",Atezolizumab (with chemotherapy) (Tecentriq),Options for investment,Hospital,Oncology Agents and Immunosuppressants
